Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway
DLX3 肿瘤抑制功能的丧失通过 EGFR-ERBB2 通路促进 SCC 进展
期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-021-01802-9
Deepti Bajpai, Spencer Mehdizadeh, Akihiko Uchiyama, Yuta Inoue, Andrew Sawaya, Andrew Overmiller, Stephen R Brooks, Kowser Hasneen, Meghan Kellett, Elisabetta Palazzo, Sei-Ichiro Motegi, Stuart H Yuspa, Christophe Cataisson, Maria I Morasso